AMED:NGS-Amedisys Inc (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 90.05

Change

-0.24 (-0.27)%

Market Cap

USD 1.35B

Volume

0.50M

Analyst Target

USD 253.14
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amedisys Inc is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The Company's operations include servicing patients through its segments home health and hospice.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 8.88B
OPCH Option Care Health Inc

N/A

USD 4.10B
SGRY Surgery Partners Inc

N/A

USD 3.65B
ACHC Acadia Healthcare Company Inc

N/A

USD 3.51B
LFST Lifestance Health Group Inc

N/A

USD 2.61B
ADUS Addus HomeCare Corporation

N/A

USD 2.17B
ASTH Astrana Health Inc

N/A

USD 1.86B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.08B
HCSG Healthcare Services Group Inc

N/A

USD 0.81B
CCRN Cross Country Healthcare Inc

N/A

USD 0.38B

ETFs Containing AMED

EVNT AltShares Event-Driven ET.. 3.17 % 0.00 %

N/A

USD 4.87M
OLD 0.00 % 0.50 %

N/A

N/A
RWM ProShares Short Russell20.. 0.00 % 0.95 %

N/A

USD 0.14B
SRTY ProShares UltraPro Short .. 0.00 % 0.95 %

N/A

USD 0.07B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

N/A

USD 0.05B
TZA Direxion Daily Small Cap .. 0.00 % 0.95 %

N/A

N/A
MARB First Trust Vivaldi Merge.. 0.00 % 0.00 %

N/A

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.27% 73% C 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.27% 73% C 41% F
Trailing 12 Months  
Capital Gain -3.67% 65% D 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.67% 65% D 38% F
Trailing 5 Years  
Capital Gain -41.09% 20% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.09% 20% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain -10.83% 38% F 20% F
Dividend Return -10.83% 38% F 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 35.75% 62% D 53% F
Risk Adjusted Return -30.28% 35% F 20% F
Market Capitalization 1.35B 83% B 84% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 32.60 50% 28%
Price/Book Ratio 2.58 35% 40%
Price / Cash Flow Ratio 21.50 17% 14%
Price/Free Cash Flow Ratio 14.06 43% 26%
Management Effectiveness  
Return on Equity 7.21% 73% 71%
Return on Invested Capital 7.17% 67% 72%
Return on Assets 6.27% 93% 89%
Debt to Equity Ratio 33.93% 52% 51%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector